A detailed history of Vanguard Group Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,152,719 shares of CDXS stock, worth $21.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,152,719
Previous 4,091,230 1.5%
Holding current value
$21.9 Million
Previous $12.7 Million 0.85%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.62 - $3.71 $161,101 - $228,124
61,489 Added 1.5%
4,152,719 $12.8 Million
Q2 2024

Aug 13, 2024

SELL
$2.65 - $3.92 $442,473 - $654,526
-166,971 Reduced 3.92%
4,091,230 $12.7 Million
Q1 2024

May 10, 2024

BUY
$2.59 - $4.65 $336,112 - $603,444
129,773 Added 3.14%
4,258,201 $14.9 Million
Q4 2023

Feb 14, 2024

BUY
$1.54 - $3.37 $138,111 - $302,231
89,683 Added 2.22%
4,128,428 $12.6 Million
Q3 2023

Nov 14, 2023

BUY
$1.5 - $3.75 $520,369 - $1.3 Million
346,913 Added 9.4%
4,038,745 $7.63 Million
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.43 $146,874 - $294,413
-66,459 Reduced 1.77%
3,691,832 $10.3 Million
Q1 2023

May 15, 2023

BUY
$3.81 - $6.76 $442,276 - $784,721
116,083 Added 3.19%
3,758,291 $15.6 Million
Q4 2022

Feb 10, 2023

BUY
$4.26 - $6.84 $540,159 - $867,298
126,798 Added 3.61%
3,642,208 $17 Million
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $177,412 - $376,489
29,276 Added 0.84%
3,515,410 $21.3 Million
Q2 2022

Aug 12, 2022

SELL
$8.35 - $21.89 $1.22 Million - $3.2 Million
-146,228 Reduced 4.03%
3,486,134 $36.5 Million
Q1 2022

May 13, 2022

BUY
$16.97 - $31.93 $3.93 Million - $7.4 Million
231,872 Added 6.82%
3,632,362 $74.9 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $4.76 Million - $7.77 Million
185,898 Added 5.78%
3,400,490 $106 Million
Q3 2021

Nov 12, 2021

BUY
$19.65 - $27.99 $582,740 - $830,071
29,656 Added 0.93%
3,214,592 $74.8 Million
Q2 2021

Aug 13, 2021

BUY
$17.48 - $25.46 $55.7 Million - $81.1 Million
3,184,936 New
3,184,936 $72.2 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $346M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.